Healthcare Professional Blog

Education Library

 

DanGer Shock Results from Dr. Jacob Møller at ACC 2024

Jacob Møller, MD, the principal investigator of the DanGer Shock trial, discusses study results he presented at ACC 2024.

Sign Up for Latest Updates

Stay up-to-date on the latest clinical data and resources.

All Posts

Filter Results

Condition

Audience

Topic

Type

Improving Survival in Cardiogenic Shock—A Propensity Score-Matched Analysis of the Impact of an Institutional Allocation Protocol to Short-Term Mechanical Circulatory Support

In this paper, Sascha Ott and colleagues describe a standard operating procedure (SOP) they developed for determining the temporary mechanical circulatory support (tMCS) strategy for patients in cardiogenic shock (CS).

ECpella in Refractory Cardiac Arrest

Prof. Carsten Skurk, MD, and Tharusan Thevathasan, MD, discuss ECMELLA support — VA ECMO and Impella CP® heart pump — in refractory cardiac arrest.

How to Achieve Better Outcomes in PCCS

Prof. Dr. med. Gregor Warnecke discusses how to achieve better outcomes in patients with postcardiotomy cardiogenic shock (PCCS).

The ECpella 2+ Concept

Prof. Evgenij Potapov explains how “ECpella 2+” achieves over 50% survival in patients with very severe cardiogenic shock while minimizing complications and enabling mobilization.

Prof. Evgenij Potapov : SOPs for Cardiogenic Shock

Prof. Evgenij Potapov discusses improved survival in patients who were treated at his institution with standard operating procedures (SOPs) for cardiogenic shock.

85% Survival with Impella 5.5® with SmartAssist® Heart Pump ECpella

Alan Gass, MD, discusses data from successful management of patients with Impella 5.5® with SmartAssist® heart pump and ECMO.

ELSO 2022 Q&A with Evgenij Potapov, Roberto Lorusso, and Alan Gass

Roberto Lorusso, MD, Alan Gass, MD, and Evgenij Potapov, MD, discuss topics related to ECpella and LV unloading in this Q&A session from ELSO 2022.

ECMO-CS Trial: VA ECMO in Rapidly Deteriorating or Severe Cardiogenic Shock

Prof. Jan Belohlavek, MD, discusses ECMO CS trial results comparing immediate VA ECMO with conservative therapy allowing VA ECMO downstream in severe cardiogenic shock.

Specific Clinical Vignettes in High-Risk Protected Percutaneous Coronary Intervention

This article presents 3 case vignettes that provide practical insights and reinforce best practices. The authors emphasize that several cardiac and patient-related factors come into play when considering patients for Protected percutaneous coronary intervention (PCI).

Handling High-Risk Patients in the Catheterization Laboratory

This article describes how the interventional cardiology team handles high-risk patients in the cath lab, from procedural preparation and planning through procedural monitoring, as well as weaning strategies and access site management.

Defining the Optimal Revascularization Strategy During Protected High-Risk Procedures With Impella Heart Pumps

This article explores optimal revascularization strategies for patients undergoing Protected PCI.

What Is Known in Pre-, Peri-, and Post-Procedural Anticoagulation in Micro-Axial Flow Pump Protected Percutaneous Coronary Intervention?

“The precarious balance between bleeding and thrombosis in patients with p-LVAD support is often the primary reason that patients’ outcomes are jeopardized,” write the authors of this article, which discusses anticoagulation strategies and anticoagulant management in the setting of Protected PCI.

Standardized Pre-Procedural Clinical Workup for Protected Percutaneous Coronary Intervention

This article describes pre-procedural preparation, with a particular focus on imaging techniques for screening and guiding vascular access in patients undergoing Protected PCI.

Optimized Patient Selection in High-Risk Protected Percutaneous Coronary Intervention

Patients undergoing elective high-risk PCI are often in critical condition and not candidates for coronary artery bypass graft (CABG) surgery.

European Best Practice: A Step Forward to Optimize Impella-Protected Percutaneous Coronary Intervention to Improve Outcome After High-Risk Coronary Interventions

This overview article provides a framework for this series of articles. It addresses European recommendations and best practices for patient management and mechanical circulatory support (MCS)during high risk intervention, highlighting the following topics...

Subscribe for Our Healthcare Professional Newsletter

Subscribe for Our Healthcare Professional Newsletter

By subscribing you will receive our HeartRecovery newsletter for healthcare professionals with latest Impella® device news about recordings, interviews, upcoming and past events or clinical evidence.

CAMP PCI™

A Community Created by Physicians for Physicians

CAMP PCI was developed by physicians for physicians in an effort to respond to a growing crisis in coronary artery disease and heart failure.

Downloads

Discover further resources like brochures, data sheets and indications for use.

NPS-891

This information is intended for use by customers, patients, and healthcare professionals in [region] only. We recognize that the Internet is a global communications medium; however, laws, regulatory requirements, and product information for medical products can vary from country to country. The product information included here may not be appropriate for use outside [region], and the information from other sites you visit may not be appropriate for use in [region].